These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16093474)

  • 21. Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation.
    Batcher EL; Tang XC; Singh BN; Singh SN; Reda DJ; Hershman JM;
    Am J Med; 2007 Oct; 120(10):880-5. PubMed ID: 17904459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of atrial fibrillation in the postoperative cardiac patient: significance of oral class III antiarrhythmic agents.
    Morady F
    Am J Cardiol; 1999 Nov; 84(9A):156R-160R. PubMed ID: 10568676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality risk of sotalol and amiodarone for post-CABG atrial fibrillation.
    Johnson SM; Brophy JM
    Int J Cardiol; 2016 Jul; 214():502-7. PubMed ID: 27107151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial arrhythmias after lung and heart-lung transplant: effects on short-term mortality and the influence of amiodarone.
    Isiadinso I; Meshkov AB; Gaughan J; Sandhu P; Lim S; Cordova F; Criner G
    J Heart Lung Transplant; 2011 Jan; 30(1):37-44. PubMed ID: 21145475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone for atrial fibrillation.
    Kurnik D; Loebstein R; Olchovsky D
    N Engl J Med; 2007 Jun; 356(23):2424-6; author reply 2424-6. PubMed ID: 17561530
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyponatremia induced by amiodarone therapy.
    Shavit E; Sherer Y
    Isr Med Assoc J; 2007 Jul; 9(7):564-5. PubMed ID: 17710795
    [No Abstract]   [Full Text] [Related]  

  • 29. Dronedarone (Multaq) for atrial fibrillation.
    Med Lett Drugs Ther; 2009 Oct; 51(1322):78-80. PubMed ID: 19798011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Amiodarone-induced thyrotoxicosis--a predictable complication].
    Lindstedt G
    Lakartidningen; 2005 Jul 25-Aug 7; 102(30-31):2167-8. PubMed ID: 16111111
    [No Abstract]   [Full Text] [Related]  

  • 31. Understanding amiodarone-induced hypothyroidism.
    Kessenich CR; Higgs DA
    Nurse Pract; 2010 Jun; 35(6):14-5. PubMed ID: 20479621
    [No Abstract]   [Full Text] [Related]  

  • 32. Rhythm control agents and adverse events in patients with atrial fibrillation.
    Taylor CJ; Hodgkinson J; Hobbs FD
    Int J Clin Pract; 2010 Jul; 64(8):1069-75. PubMed ID: 20487051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiodarone related rare toxicity in a burn patient.
    Maheshwari M; Baid JC; Vijayvergia A
    Burns; 2007 May; 33(3):387-92. PubMed ID: 17140738
    [No Abstract]   [Full Text] [Related]  

  • 34. Amiodarone-induced acute lung toxicity in an ICU setting.
    Venkatesan T; Ninan S
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):520-1. PubMed ID: 16548873
    [No Abstract]   [Full Text] [Related]  

  • 35. Amiodarone and optic neuropathy.
    Mindel JS
    Am Heart J; 2008 Sep; 156(3):411-3. PubMed ID: 18760119
    [No Abstract]   [Full Text] [Related]  

  • 36. Amiodarone induced pulmonary toxicity in a case of atrial fibrillation.
    Sirsikar SS; Ranpise SM; Patil AS; Deodhar KY
    J Assoc Physicians India; 2014 Apr; 62(4):347-9. PubMed ID: 25327042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Images in cardiology. Blue-grey cutaneous discolouration secondary to amiodarone treatment.
    Nikolidakis S; Kyriakides ZS; Barbatis C
    Heart; 2006 Apr; 92(4):436. PubMed ID: 16537754
    [No Abstract]   [Full Text] [Related]  

  • 38. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy.
    Singh SN; Tang XC; Singh BN; Dorian P; Reda DJ; Harris CL; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Lopez B; Raisch DW; Ezekowitz MD;
    J Am Coll Cardiol; 2006 Aug; 48(4):721-30. PubMed ID: 16904540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe ataxia caused by amiodarone.
    Kashyap AS; Anand KP; Kashyap S
    Am J Cardiol; 2006 May; 97(10):1550-1. PubMed ID: 16679106
    [No Abstract]   [Full Text] [Related]  

  • 40. Facial hyperpigmentation. amiodarone-induced hyperpigmentation.
    e Silva LP; Luís F; Cabrera H
    Am Fam Physician; 2008 Dec; 78(11):1297-8. PubMed ID: 19069023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.